Aiforia vs AIRA Matrix (2026)

AI Health Index verifiedNovember 16, 2026
Verdict

Aiforia and AIRA Matrix both sell deep learning image analysis for pathology to laboratories and drug developers, and the line between them is regulatory. Aiforia's Clinical Suites cover breast, lung, prostate, gastric and colon cancer on a platform with a worklist, viewer and reporting, and many of its models are CE IVD marked for diagnostic use in the EU and EEA under the IVDR, though research use only in the United States. Aiforia Create lets labs build their own models, and named clinical users include AP-HP, Institut Curie and an NHS trust. AIRA Matrix, based in Thane, India, labels its products Research Use Only. AIRAProstate classifies Gleason patterns on prostate biopsies and prostatectomies, and AIRAQc checks whole slide images for artifacts against thresholds a lab sets. On the preclinical side, AIRATox triages toxicology study slides on a self supervised model trained on 130,000 images across six species, PredTox predicts organ toxicity from compound data and AIRADHI manages GLP studies. Peer reviewed studies with Johns Hopkins, Radboud University Medical Center and LabCorp cover its prostate and toxicology models. For diagnostic sign out in Europe, Aiforia's CE IVD models carry the regulatory basis; for preclinical toxicology and compound screening, AIRA Matrix sells tools built for that work. Both run on Sectra and Techcyte platforms and build their own models. Aiforia names ISO 27001, SOC 2 Type II and an audit of its HIPAA Security Rule controls; AIRA Matrix names no security attestation or HIPAA position and offers on premise deployment. Neither publishes a price.

The case for Aiforia
  • CE IVD marked clinical models under the IVDR for breast, prostate, lung and gastric cancer, for diagnostic use in the EU and EEA.
  • A clinical platform with worklist, viewer and case reporting, where overlays mark each finding for the pathologist to confirm.
  • Aiforia Create lets a laboratory or research team build its own deep learning models.
  • Integrations with Dedalus InVitro and GPI PATHOXWEB laboratory systems, Sectra and Techcyte, and its models are also offered inside PathAI's AISight Dx.
  • ISO 27001, SOC 2 Type II, ISO 13485 and an independent audit of HIPAA Security Rule controls.
The case for AIRA Matrix
  • AIRATox screens, triages and quantifies findings in toxicology studies across species, on a model trained on 130,000 whole slide images.
  • PredTox predicts in vivo organ toxicity from compound data on a desktop platform, keeping molecule information inside the organization.
  • AIRAQc accepts or flags each slide for rescanning against artifact thresholds the lab sets, with 95% sensitivity and 96% specificity reported.
  • AIRADHI manages GLP studies with audit trails and electronic signatures for 21 CFR Part 11, in the cloud or on premise.
  • Prostate cancer models studied with Johns Hopkins and in a Radboud evaluation of Gleason algorithms on outside data, offered as Research Use Only.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Aiforia and AIRA Matrix are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Aiforia AIRA Matrix
Primary category Digital Pathology AI Digital Pathology AI
Founded 2013 Not recorded
Headquarters Helsinki, Finland Thane, Maharashtra, India
Website aiforia.com airamatrix.com
Attribute Matrix

Side by Side

Select any grade to read the note behind it.

Axis
A
Aiforia
A
AIRA Matrix
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Change Log

Product updates

The latest logged changes from each vendor, newest first, each linked to its source.

Aiforia

  • Product / capability

    Aiforia released version 8.0 of Aiforia Create, its tool for building deep learning models for pathology image analysis without writing code.

    Source
All 1 Aiforia update →
Citable Summaries

Each vendor in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached.

Aiforia

Aiforia, listed in Helsinki, sells cloud based deep learning image analysis for pathology: Clinical Suites for breast, lung, prostate, gastric and colon cancer, many CE IVD marked for diagnostic use in the EU and EEA, and Aiforia Create for building custom models. It integrates with laboratory and image systems from Dedalus, GPI, Sectra and Techcyte, names clinical users such as AP-HP and Institut Curie, and lists ISO 27001 and SOC 2 Type II. Its products are research use only in the United States, and pricing is not published.

Source: AI Health Index, November 2026

AIRA Matrix

AIRA Matrix, based in Thane, India, sells deep learning pathology tools labeled Research Use Only: AIRATox, PredTox and AIRADHI for preclinical toxicology and drug development, AIRAProstate for prostate cancer analysis and AIRAQc for slide quality control, in the cloud or on premise. Its algorithms are offered through Sectra, Techcyte, Gestalt and Lumea, and peer reviewed studies with Johns Hopkins, Radboud University Medical Center and LabCorp cover its models. No security attestation, HIPAA position or price is published.

Source: AI Health Index, November 2026

FAQ

Questions buyers ask

How does Aiforia compare with AIRA Matrix?

Both sell deep learning image analysis for pathology. Aiforia concentrates on clinical cancer diagnostics, with many models CE IVD marked in the EU and EEA, plus a tool for building custom models. AIRA Matrix labels its products Research Use Only and concentrates on preclinical toxicology and drug development, alongside prostate cancer analysis and slide quality control. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

How much do Aiforia and AIRA Matrix cost?

Neither publishes a price. Aiforia sells directly, through resellers such as GPI Group and inside PathAI's AISight Dx. AIRA Matrix sells its products through a demo and offers image analysis as a service, pay per use for small projects or by subscription. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

Can Aiforia or AIRA Matrix be used for diagnosis?

Aiforia's CE IVD marked models can be used for diagnosis in EU and EEA countries; in the United States and other markets its models are for research use only. AIRA Matrix labels its products Research Use Only and not for use in diagnostic procedures, and Sectra's marketplace lists AIRAProstate as research only. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

Do Aiforia and AIRA Matrix support preclinical research?

Yes. Aiforia Create lets researchers build their own models, and academic work using it appears in published studies. AIRA Matrix sells preclinical products directly: AIRATox for toxicology study slides across species, PredTox for toxicity prediction from compound data, and AIRADHI for GLP image management with 21 CFR Part 11 controls. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

How do Aiforia and AIRA Matrix handle security and data?

Aiforia names ISO 27001:2022, a SOC 2 Type II report and an independent audit of its HIPAA Security Rule controls, but no cloud host or region. AIRA Matrix names no security attestation and no HIPAA position, and offers cloud or on premise deployment, with PredTox running on the desktop so compound data stays inside the organization. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Digital Pathology AI page.

Disclosure

Neither Aiforia nor AIRA Matrix publishes a price, results by scanner, stain, site or patient group, or a privacy document covering slide images, and neither has a US clearance; both label their products research use only in the United States.

Aiforia's CE IVD marks cover named models only, and some, such as QuantCRC, are research use only everywhere. It names no cloud host or region and states no retention or training position for customer images.

AIRA Matrix labels every product Research Use Only while its clinical pages describe diagnosis and treatment planning. It names no security attestation beyond an ISO 9001 quality certificate, states no HIPAA position and names no host for its cloud deployment, and its accuracy figures are given as up to values without the dataset behind them.